vs

Side-by-side financial comparison of Babcock & Wilcox Enterprises, Inc. (BW) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $113.4M, roughly 2.0× Babcock & Wilcox Enterprises, Inc.). On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 0.6%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $-7.2M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -16.9%).

Babcock & Wilcox Enterprises, Inc. is an American energy technology and service provider that is active and has operations in many international markets with its headquarters in Akron, Ohio. Historically, the company is best known for their steam boilers.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

BW vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
2.0× larger
ORGO
$225.6M
$113.4M
BW
Growing faster (revenue YoY)
ORGO
ORGO
+77.5% gap
ORGO
78.1%
0.6%
BW
More free cash flow
ORGO
ORGO
$41.9M more FCF
ORGO
$34.8M
$-7.2M
BW
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-16.9%
BW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BW
BW
ORGO
ORGO
Revenue
$113.4M
$225.6M
Net Profit
$43.7M
Gross Margin
20.6%
Operating Margin
0.2%
28.1%
Net Margin
19.4%
Revenue YoY
0.6%
78.1%
Net Profit YoY
469.5%
EPS (diluted)
$0.11
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BW
BW
ORGO
ORGO
Q4 25
$113.4M
$225.6M
Q3 25
$149.0M
$150.9M
Q2 25
$144.1M
$101.0M
Q1 25
$181.2M
$86.7M
Q4 24
$112.7M
$126.7M
Q3 24
$152.6M
$115.2M
Q2 24
$151.4M
$130.2M
Q1 24
$164.3M
$110.0M
Net Profit
BW
BW
ORGO
ORGO
Q4 25
$43.7M
Q3 25
$35.1M
$21.6M
Q2 25
$-58.5M
$-9.4M
Q1 25
$-22.0M
$-18.8M
Q4 24
$-63.1M
$7.7M
Q3 24
$-5.3M
$12.3M
Q2 24
$25.4M
$-17.0M
Q1 24
$-16.8M
$-2.1M
Gross Margin
BW
BW
ORGO
ORGO
Q4 25
20.6%
Q3 25
24.9%
Q2 25
30.0%
Q1 25
22.1%
72.6%
Q4 24
16.7%
75.5%
Q3 24
23.7%
76.7%
Q2 24
21.8%
77.6%
Q1 24
23.6%
73.9%
Operating Margin
BW
BW
ORGO
ORGO
Q4 25
0.2%
28.1%
Q3 25
4.4%
13.7%
Q2 25
5.6%
-12.5%
Q1 25
3.2%
-30.9%
Q4 24
-8.1%
8.1%
Q3 24
1.0%
5.4%
Q2 24
-2.9%
-10.7%
Q1 24
3.5%
-3.5%
Net Margin
BW
BW
ORGO
ORGO
Q4 25
19.4%
Q3 25
23.5%
14.3%
Q2 25
-40.6%
-9.3%
Q1 25
-12.1%
-21.7%
Q4 24
-56.0%
6.1%
Q3 24
-3.5%
10.7%
Q2 24
16.8%
-13.1%
Q1 24
-10.2%
-1.9%
EPS (diluted)
BW
BW
ORGO
ORGO
Q4 25
$0.11
$0.31
Q3 25
$0.30
$0.11
Q2 25
$-0.63
$-0.10
Q1 25
$-0.26
$-0.17
Q4 24
$-0.73
$0.05
Q3 24
$-0.10
$0.09
Q2 24
$0.24
$-0.13
Q1 24
$-0.23
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BW
BW
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$89.5M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-131.5M
$300.1M
Total Assets
$662.9M
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BW
BW
ORGO
ORGO
Q4 25
$89.5M
$93.7M
Q3 25
$25.2M
$63.7M
Q2 25
$23.4M
$73.1M
Q1 25
$23.5M
$110.0M
Q4 24
$26.9M
$135.6M
Q3 24
$30.6M
$94.3M
Q2 24
$95.5M
$89.9M
Q1 24
$43.9M
$88.6M
Total Debt
BW
BW
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
BW
BW
ORGO
ORGO
Q4 25
$-131.5M
$300.1M
Q3 25
$-232.2M
$255.1M
Q2 25
$-309.2M
$233.2M
Q1 25
$-303.0M
$242.9M
Q4 24
$-283.8M
$262.9M
Q3 24
$-203.7M
$278.5M
Q2 24
$-198.9M
$263.5M
Q1 24
$-223.0M
$278.0M
Total Assets
BW
BW
ORGO
ORGO
Q4 25
$662.9M
$598.7M
Q3 25
$657.9M
$509.8M
Q2 25
$703.5M
$461.1M
Q1 25
$719.7M
$467.4M
Q4 24
$727.0M
$497.9M
Q3 24
$804.6M
$446.3M
Q2 24
$849.1M
$443.2M
Q1 24
$795.5M
$458.5M
Debt / Equity
BW
BW
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BW
BW
ORGO
ORGO
Operating Cash FlowLast quarter
$-3.0M
$39.4M
Free Cash FlowOCF − Capex
$-7.2M
$34.8M
FCF MarginFCF / Revenue
-6.3%
15.4%
Capex IntensityCapex / Revenue
3.7%
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-85.7M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BW
BW
ORGO
ORGO
Q4 25
$-3.0M
$39.4M
Q3 25
$-32.1M
$3.1M
Q2 25
$-25.3M
$-32.9M
Q1 25
$-8.5M
$-19.9M
Q4 24
$-22.5M
$10.9M
Q3 24
$-69.5M
$8.7M
Q2 24
$-11.8M
$4.7M
Q1 24
$-14.9M
$-10.2M
Free Cash Flow
BW
BW
ORGO
ORGO
Q4 25
$-7.2M
$34.8M
Q3 25
$-37.6M
$844.0K
Q2 25
$-28.1M
$-36.5M
Q1 25
$-12.8M
$-23.6M
Q4 24
$-23.6M
$7.6M
Q3 24
$-71.6M
$6.1M
Q2 24
$-16.4M
$2.9M
Q1 24
$-18.3M
$-12.4M
FCF Margin
BW
BW
ORGO
ORGO
Q4 25
-6.3%
15.4%
Q3 25
-25.3%
0.6%
Q2 25
-19.5%
-36.1%
Q1 25
-7.1%
-27.2%
Q4 24
-20.9%
6.0%
Q3 24
-46.9%
5.3%
Q2 24
-10.8%
2.2%
Q1 24
-11.2%
-11.3%
Capex Intensity
BW
BW
ORGO
ORGO
Q4 25
3.7%
2.1%
Q3 25
3.7%
1.5%
Q2 25
1.9%
3.6%
Q1 25
2.4%
4.2%
Q4 24
1.0%
2.7%
Q3 24
1.4%
2.2%
Q2 24
3.0%
1.4%
Q1 24
2.1%
2.0%
Cash Conversion
BW
BW
ORGO
ORGO
Q4 25
0.90×
Q3 25
-0.92×
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
-0.46×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BW
BW

Construction$98.8M87%
Other$14.6M13%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons